Annemiek Broyl

Summary

Affiliation: Erasmus MC
Country: The Netherlands

Publications

  1. ncbi General aspects and mechanisms of peripheral neuropathy associated with bortezomib in patients with newly diagnosed multiple myeloma
    Annemiek Broyl
    Erasmus MC, Rotterdam, The Netherlands
    Semin Hematol 49:249-57. 2012
  2. ncbi Gene expression profiling for molecular classification of multiple myeloma in newly diagnosed patients
    Annemiek Broyl
    Department of Hematology, Erasmus Medical Center and University, Rotterdam, The Netherlands
    Blood 116:2543-53. 2010
  3. ncbi Mechanisms of peripheral neuropathy associated with bortezomib and vincristine in patients with newly diagnosed multiple myeloma: a prospective analysis of data from the HOVON-65/GMMG-HD4 trial
    Annemiek Broyl
    Department of Haematology, Erasmus MC, Rotterdam, Netherlands
    Lancet Oncol 11:1057-65. 2010
  4. ncbi High cereblon expression is associated with better survival in patients with newly diagnosed multiple myeloma treated with thalidomide maintenance
    Annemiek Broyl
    Department of Hematology, Erasmus MC, Rotterdam, The Netherlands
    Blood 121:624-7. 2013
  5. ncbi Bortezomib induction and maintenance treatment in patients with newly diagnosed multiple myeloma: results of the randomized phase III HOVON-65/ GMMG-HD4 trial
    Pieter Sonneveld
    Erasmus Medical Center, Rotterdam, The Netherlands
    J Clin Oncol 30:2946-55. 2012
  6. ncbi Cancer testis antigens in newly diagnosed and relapse multiple myeloma: prognostic markers and potential targets for immunotherapy
    Mark van Duin
    Department of Hematology, Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands
    Haematologica 96:1662-9. 2011

Collaborators

Detail Information

Publications6

  1. ncbi General aspects and mechanisms of peripheral neuropathy associated with bortezomib in patients with newly diagnosed multiple myeloma
    Annemiek Broyl
    Erasmus MC, Rotterdam, The Netherlands
    Semin Hematol 49:249-57. 2012
    ..Here, we discuss all aspects of bortezomib-induced peripheral neuropathy (BiPN), and elaborate on the mechanisms underlying the development of BiPN...
  2. ncbi Gene expression profiling for molecular classification of multiple myeloma in newly diagnosed patients
    Annemiek Broyl
    Department of Hematology, Erasmus Medical Center and University, Rotterdam, The Netherlands
    Blood 116:2543-53. 2010
    ..To conclude, in addition to 7 clusters described in the UAMS classification, we identified 3 novel subsets of multiple myeloma that may represent unique diagnostic entities...
  3. ncbi Mechanisms of peripheral neuropathy associated with bortezomib and vincristine in patients with newly diagnosed multiple myeloma: a prospective analysis of data from the HOVON-65/GMMG-HD4 trial
    Annemiek Broyl
    Department of Haematology, Erasmus MC, Rotterdam, Netherlands
    Lancet Oncol 11:1057-65. 2010
    ....
  4. ncbi High cereblon expression is associated with better survival in patients with newly diagnosed multiple myeloma treated with thalidomide maintenance
    Annemiek Broyl
    Department of Hematology, Erasmus MC, Rotterdam, The Netherlands
    Blood 121:624-7. 2013
    ..trialregister.nl) as NTR213; at the European Union Drug Regulating Authorities Clinical Trials (EudraCT) as 2004-000944-26; and at the International Standard Randomized Controlled Trial Number (ISRCTN) as 64455289...
  5. ncbi Bortezomib induction and maintenance treatment in patients with newly diagnosed multiple myeloma: results of the randomized phase III HOVON-65/ GMMG-HD4 trial
    Pieter Sonneveld
    Erasmus Medical Center, Rotterdam, The Netherlands
    J Clin Oncol 30:2946-55. 2012
    ..We investigated whether bortezomib during induction and maintenance improves survival in newly diagnosed multiple myeloma (MM)...
  6. ncbi Cancer testis antigens in newly diagnosed and relapse multiple myeloma: prognostic markers and potential targets for immunotherapy
    Mark van Duin
    Department of Hematology, Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands
    Haematologica 96:1662-9. 2011
    ....